- Next-week expectancy is positive at 55.12% based on similar historical setup states.
ILM1
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Medios AG · Healthcare · Medical Distribution
Latest close
11.06 EUR
0.7%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -19.3% below the Trend Line and sits at 2.2% of its 52-week range. The latest completed week returned 0.7%, after a -7.5% four-week move. The latest news-sentiment score is 54/100.
Setup score
24
out of 100
Latest Close
11.06 EUR
7 Aug 2026
1W Return
0.7%
latest completed week
4W Return
-7.5%
short-term follow-through
12W Return
-10.1%
quarterly tape
Trend Breadth
44.2%
23 of 52 weeks active
Volume Ratio
-
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
0.7%
Latest completed week; four-week move -7.5%.
Indicator stack
24/39
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.12%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
54/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -19.3% below the Trend Line and sits at 2.2% of its 52-week range. The latest completed week returned 0.7%, after a -7.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1212-week average 0.12
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.5% over four weeks, -10.1% over 12 weeks, and -15.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year23
Trend breadth44.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.51Latest activity-pressure read.
Pressure change-23.5%Four-week change in activity pressure.
Leadership-35.22Latest relative-leadership reading.
RS change-16.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 11 relevant articles.
2 positive · 9 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-36.4%Distance below the 52-week high.
13-week volatility6.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2612 weeks finished lower.
Best week+8.1%Week of 22 May.
Worst week-16.6%Week of 15 May.
Latest week+0.7%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains8
Flat weeks1
Modest losses3
Sharp losses9
Recent vol6.9%13-week weekly-return volatility.
Base vol6.2%52-week weekly-return volatility.
Up/down split25/25Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -5.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank- / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Medical Distribution
4-week rank5 / 5
Group average1.5%
Trend breadth20.0%
Trend20.0%active weekly trend signals
MD80.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape25/100
Trend, activity pressure, participation, and risk combine to a 25/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.12; No reversal markers Next-Week ExpectancyPositive 55.12%Next-week expectancy is positive with a 55.12% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 11 relevant articles.
Medios AG (ILM1) Q1 2026 Earnings Report - Results, Call & Slides Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 11.06 EUR | 0.7% | 13.70 EUR | 13.33 EUR | -0.51 | -35.22 | 0 | Off |
| 31 Jul 2026 | 10.98 EUR | -12.0% | 13.84 EUR | 13.36 EUR | -0.42 | -34.29 | 0 | Off |
| 24 Jul 2026 | 12.48 EUR | 0.0% | 13.96 EUR | 13.39 EUR | -0.31 | -25.92 | 0 | Off |
| 17 Jul 2026 | 12.48 EUR | 4.3% | 14.02 EUR | 13.41 EUR | -0.38 | -25.28 | 0 | Off |
| 10 Jul 2026 | 11.96 EUR | -4.2% | 14.05 EUR | 13.42 EUR | -0.42 | -30.15 | 115 | Off |
| 3 Jul 2026 | 12.48 EUR | 3.1% | 14.11 EUR | 13.44 EUR | -0.55 | -28.50 | 0 | Off |
| 26 Jun 2026 | 12.10 EUR | -5.5% | 14.18 EUR | 13.46 EUR | -0.72 | -29.46 | 0 | Off |
| 19 Jun 2026 | 12.80 EUR | 4.7% | 14.26 EUR | 13.48 EUR | -0.74 | -27.24 | 0 | Off |
| 12 Jun 2026 | 12.22 EUR | -1.6% | 14.30 EUR | 13.49 EUR | -0.84 | -27.98 | 0 | Off |
| 5 Jun 2026 | 12.42 EUR | -8.9% | 14.37 EUR | 13.51 EUR | -0.86 | -25.07 | 0 | Off |
| 29 May 2026 | 13.64 EUR | 2.6% | 14.37 EUR | 13.52 EUR | -0.76 | -18.95 | 0 | Off |
| 22 May 2026 | 13.30 EUR | 8.1% | 14.33 EUR | 13.52 EUR | -0.84 | -19.02 | 0 | Off |
| 15 May 2026 | 12.30 EUR | -16.6% | 14.31 EUR | 13.53 EUR | -0.89 | -23.81 | 0 | Off |
| 8 May 2026 | 14.74 EUR | 7.9% | 14.33 EUR | 13.55 EUR | -0.87 | -9.42 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.